Kodiak Sciences, Inc. (KOD)
99.87
+5.61
(+5.95%)
USD |
NASDAQ |
Oct 09, 16:00
100.13
+0.26
(+0.26%)
After-Hours: 20:00
Kodiak Sciences Market Cap : 6.275B for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 6.275B |
| October 08, 2026 | 5.922B |
| October 07, 2026 | 5.723B |
| October 06, 2026 | 5.802B |
| October 05, 2026 | 5.894B |
| October 02, 2026 | 5.934B |
| October 01, 2026 | 6.186B |
| September 30, 2026 | 5.956B |
| September 29, 2026 | 5.725B |
| September 28, 2026 | 5.650B |
| September 25, 2026 | 2.033B |
| September 24, 2026 | 2.087B |
| September 23, 2026 | 1.980B |
| September 22, 2026 | 2.124B |
| September 21, 2026 | 2.037B |
| September 18, 2026 | 2.055B |
| September 17, 2026 | 2.064B |
| September 16, 2026 | 2.059B |
| September 15, 2026 | 2.073B |
| September 14, 2026 | 2.082B |
| September 11, 2026 | 2.067B |
| September 10, 2026 | 2.065B |
| September 09, 2026 | 2.122B |
| September 08, 2026 | 2.203B |
| September 04, 2026 | 2.222B |
| Date | Value |
|---|---|
| September 03, 2026 | 2.285B |
| September 02, 2026 | 2.356B |
| September 01, 2026 | 2.329B |
| August 31, 2026 | 2.347B |
| August 28, 2026 | 2.370B |
| August 27, 2026 | 2.458B |
| August 26, 2026 | 2.471B |
| August 25, 2026 | 2.479B |
| August 24, 2026 | 2.339B |
| August 21, 2026 | 2.408B |
| August 20, 2026 | 2.503B |
| August 19, 2026 | 2.518B |
| August 18, 2026 | 2.554B |
| August 17, 2026 | 2.575B |
| August 14, 2026 | 2.598B |
| August 13, 2026 | 2.512B |
| August 12, 2026 | 2.727B |
| August 11, 2026 | 2.646B |
| August 10, 2026 | 2.698B |
| August 07, 2026 | 2.820B |
| August 06, 2026 | 2.822B |
| August 05, 2026 | 2.711B |
| August 04, 2026 | 2.666B |
| August 03, 2026 | 2.476B |
| July 31, 2026 | 2.584B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 77.19B |
| AbbVie, Inc. | 488.54B |
| Mirum Pharmaceuticals, Inc. | 5.570B |
| ACADIA Pharmaceuticals, Inc. | 3.405B |
| Alnylam Pharmaceuticals, Inc. | 31.12B |
Market Cap Related Metrics
| PEG Ratio | -2.247 |
| Price to Book Value | 102.71 |
| Price | 99.87 |
| Earnings Yield | -4.20% |
| PEGY Ratio | -2.247 |